TOKYO -- Japan expects to have received enough of Merck's COVID-19 pills by next week to treat 340,000 people, with some shipments set to arrive weeks ahead of schedule, health minister Shigeyuki Goto told reporters on Friday.
Coronavirus
More Merck COVID-19 pills headed to Japan weeks early
Tokyo anticipates enough to treat 340,000 people by Thursday
Merck headquarters in the U.S. state of New Jersey. The company's molnupiravir pill can treat patients with milder COVID-19 symptoms. © Reuters
Read Next
re.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Coronavirus
